Novozymes A/S (OTCMKTS:NVZMY) Short Interest Down 58.8% in May

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) was the recipient of a large decline in short interest in May. As of May 15th, there was short interest totalling 3,500 shares, a decline of 58.8% from the April 30th total of 8,500 shares. Approximately 0.0% of the company's stock are short sold. Based on an average daily trading volume, of 28,100 shares, the days-to-cover ratio is currently 0.1 days.

Novozymes A/S Price Performance

OTCMKTS:NVZMY traded up $1.05 on Monday, hitting $71.74. 82,091 shares of the company's stock were exchanged, compared to its average volume of 34,956. The firm has a 50-day moving average price of $64.05 and a 200-day moving average price of $59.86. Novozymes A/S has a 52 week low of $53.95 and a 52 week high of $72.77. The company has a market cap of $33.60 billion, a P/E ratio of 45.41, a price-to-earnings-growth ratio of 3.87 and a beta of 0.92.

Novozymes A/S Increases Dividend

The company also recently announced a dividend, which was paid on Wednesday, April 23rd. Stockholders of record on Monday, April 7th were issued a $0.3758 dividend. This is a boost from Novozymes A/S's previous dividend of $0.17. The ex-dividend date was Monday, April 7th. Novozymes A/S's dividend payout ratio is presently 47.47%.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.